David
April 23, 2020
Abstract Real-world LDL-C Reduction in a Nested Cohort of PCSK9 Inhibitor Patients Feolo, DA, Biskupiak, JE Objectives: Proprotein Convertase Subtilisin Kexin Type 9 inhibitors (PCSK9i)…
April 23, 2020
Abstract Real-world LDL-C Reduction in a Nested Cohort of PCSK9 Inhibitor Patients Feolo, DA, Biskupiak, JE Objectives: Proprotein Convertase Subtilisin Kexin Type 9 inhibitors (PCSK9i)…